WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, August 29, 2007, 27(35):9525-9533; doi:10.1523/JNEUROSCI.0579-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matute, C.
Right arrow Articles by Domercq, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matute, C.
Right arrow Articles by Domercq, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

 Previous Article

Neurobiology of Disease
P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

Carlos Matute,1 Iratxe Torre,1 Fernando Pérez-Cerdá,1 Alberto Pérez-Samartín,1 Elena Alberdi,1 Estibaliz Etxebarria,1 Amaia M. Arranz,1 Rivka Ravid,2 Alfredo Rodríguez-Antigüedad,3 MaríaVictoria Sánchez-Gómez,1 and María Domercq1

1Departamento de Neurociencias, Universidad del País Vasco, 48940 Leioa, Spain, 2Netherland Brain Bank, 1105 AZ Amsterdam ZO, The Netherlands, and 3Servicio de Neurología, Hospital de Basurto, 48008 Bilbao, Spain

Correspondence should be addressed to Carlos Matute, Departamento de Neurociencias, Universidad del País Vasco, 48940 Leioa, Spain. Email: carlos.matute{at}ehu.es

Oligodendrocyte death and demyelination are hallmarks of multiple sclerosis (MS). Here we show that ATP signaling can trigger oligodendrocyte excitotoxicity via activation of calcium-permeable P2X7 purinergic receptors expressed by these cells. Sustained activation of P2X7 receptors in vivo causes lesions that are reminiscent of the major features of MS plaques, i.e., demyelination, oligodendrocyte death, and axonal damage. In addition, treatment with P2X7 antagonists of chronic experimental autoimmune encephalomyelitis (EAE), a model of MS, reduces demyelination and ameliorates the associated neurological symptoms. Together, these results indicate that ATP can kill oligodendrocytes via P2X7 activation and that this cell death process contributes to EAE. Importantly, P2X7 expression is elevated in normal-appearing axon tracts in MS patients, suggesting that signaling through this receptor in oligodendrocytes may be enhanced in this disease. Thus, P2X7 receptor antagonists may be beneficial for the treatment of MS.

Key words: oligodendrocytes; ATP; excitotoxicity; demyelination; EAE; multiple sclerosis

Received Feb. 9, 2007; revised July 12, 2007; accepted July 13, 2007.

Correspondence should be addressed to Carlos Matute, Departamento de Neurociencias, Universidad del País Vasco, 48940 Leioa, Spain. Email: carlos.matute{at}ehu.es


Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2007 27: i. [Full Text]  





-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-